STAAR Surgical Company (NASDAQ:STAA)

CAPS Rating: 2 out of 5

The Company develops and manufactures minimally invasive visual implants and other ophthalmic products to improve or correct the vision of patients with cataracts and refractive conditions and distributes them worldwide.


Player Avatar EclecticRecluse (80.31) Submitted: 8/17/2010 12:54:36 PM : Underperform Start Price: $4.90 STAA Score: -2.95

Increasingly Excessive P/E

Featured Broker Partners